保隆科技(603197.SH)監事蘭瑞林擬減持不超21.96萬股
格隆匯11月8日丨保隆科技(603197.SH)公佈,在本次減持計劃實施前,公司監事蘭瑞林持有公司股票87.86萬股,佔公司總股本的0.53%。
蘭瑞林擬自2019年12月2日至2020年5月29日期間通過集中競價方式減持數量不超過21.96萬股公司股份(佔公司總股本的0.13%,佔本人所持公司股份總數24.99%)。通過集中競價方式減持於保隆科技公告日起十五個交易日後進行,減持價格按市場價格確定,且不低於發行價格。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.